Postoperative pulmonary complications are major causes of postoperative morbidity and mortality. Although several risk factors have been associated with postoperative pulmonary complications, they are not consistent between studies and, even in those studies in which these factors were identified, the predictive power is low. We hypothesized that postoperative pulmonary complications would correlate with the presence of intraoperative expiratory flow limitation.
Candidates for this prospective observational study were patients undergoing general anesthesia for major abdominal surgery. Preoperative data collection included age, body mass index, American Society of Anesthesiologists class, smoking and dyspnea history, and room air PO2. Expiratory flow limitation was assessed intraoperatively using the positive end-expiratory pressure test. Postoperative data collection included the incidence of postoperative pulmonary complications.
Of the 330 patients we enrolled, 31% exhibited expiratory flow limitation. On univariate analysis, patients with expiratory flow limitation were more likely to have postoperative pneumonia (5% vs 0%, P < .001) and acute respiratory failure (11% vs 1%, P < .001) and a longer length of hospital stay (7 vs 9 days, P < .01). Multivariate analysis identified that expiratory flow limitation increased the risk of developing postoperative pulmonary complications by >50% (risk ratio, 2.7; 95% confidence interval, 1.7–4.2). Age and Medical Research Council dyspnea score were also significant multivariate risk factors for pulmonary complications.
Our results show that intraoperative expiratory flow limitation correlates with that of postoperative pulmonary complication after major abdominal surgery. Further work is needed to better understand the relevance of expiratory flow limitation on postoperative pulmonary outcomes.
Supplemental Digital Content is available in the text.Published ahead of print August 17, 2016.
From the *Dipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Unità Operativa di Anestesia e Rianimazione, Azienda Ospedaliero-Universitaria S. Anna, Università di Ferrara, Ferrara, Italy; †Centro Interdipartimentale per lo Studio delle Malattie Infiammatorie delle Vie Aeree e Patologie Fumo-correlate (CEMICEF; formerly Centro di Ricerca su Asma e BPCO), Sezione di Medicina Interna e Cardiorespiratoria, Università di Ferrara, Ferrara, Italy; ‡Dipartimento di Scienze Clinico-Chirurgiche, Diagnostiche e Pediatriche, Sezione di Anestesia Rianimazione e Terapia Antalgica, Università degli Studi di Pavia, Pavia, Italy; and §Ufficio Ricerca e Innovazione, Azienda Ospedaliero-Universitaria S. Anna, Università di Ferrara, Ferrara, Italy.
Published ahead of print August 17, 2016.
Accepted for publication April 27, 2016.
Funding: This study was financially supported by the University of Ferrara, Italy.
The authors declare no conflicts of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website.
Reprints will not be available from the authors.
Address correspondence to Savino Spadaro, MD, Dipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Università di Ferrara, Via Aldo Moro, 8 44124 Ferrara, Italy. Address e-mail to firstname.lastname@example.org.